Pharmacy Creations Recalls Ascorbic Acid Injection Due to Sterility Failure
Pharmacy Creations is recalling 67 vials of Ascorbic Acid 500 mg/mL Sterile Injection because contract testing indicated the product may not be sterile.
The agency’s classification
FDA (Drugs): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 5/5 (Critical).
Highest-severity recall. The hazard can cause serious injury or death. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The agency classification is FDA Class I, which mandates a severity score of 5 according to the rubric.
Plain-English summary
Pharmacy Creations is recalling 67 vials of Ascorbic Acid 500 mg/mL Sterile Injection, 50mL Multi-dose Vial. The recall was initiated after failing sterility results were obtained from the firm's contract testing facility, indicating that the products may not be sterile.
The affected product is prescription-only and was distributed directly to patients and physicians in Florida, New Jersey, New York, and Puerto Rico. The specific lot number is 05082014@7, with an expiration date of 11/04/2014.
Consumers and healthcare providers should stop using the recalled product and contact Pharmacy Creations at (973) 328-8756 for further instructions.
The recalled product
- Product
- Ascorbic Acid 500 mg/mL Sterile Injection, 50mL Multi-dose Vial, Rx only, Pharmacy Creations, Randolph, NJ 07869 (973) 328-8756.
- Manufacturer
- Pharmacy Creations
- Category
- Drug — Sterile Injection
- Hazard
- Affected units
- 67
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 05082014@7
- Exp 11/04/2014
Distribution
Part of a larger recall action
This product is one of 4 recalled by Pharmacy Creations under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · Pharmacy Creations
See all →- CriticalGlutathione Injection Recalled for Potential Non-Sterility
FDA (Drugs) · 2014-12-31
- CriticalPharmacy Creations Recalls Non-Sterile Ophthalmic Solution
FDA (Drugs) · 2014-12-31
- CriticalPharmacy Creations Recalls Magnesium Chloride Injection Due to Sterility Concerns
FDA (Drugs) · 2014-12-31
- CriticalPharmacy Creations Recalls Ascorbic Acid Injection Vials Due to Mold Contamination
FDA (Drugs) · 2014-08-27
- SeverePharmacy Creations Recalls EDTA Disodium Injection Due to Sterility Concerns
FDA (Drugs) · 2013-09-18
Same hazard · non sterility
See all →- SevereChloraPrep One-Step Antiseptic Solution Recall Due to Sterility Concerns
FDA (Drugs) · 2026-07-01
- SevereChloraPrep One-Step Topical Antiseptic Recalled for Non-Sterility
FDA (Drugs) · 2026-07-01
- SevereLSL Healthcare Infant Central Line Dressing Change Kit Recalled
FDA (Devices) · 2026-04-29
- HighLSL Healthcare Central Line Dressing Change Kit Recalled for Non-Sterility
FDA (Devices) · 2026-04-29
- HighLSL Healthcare Wound Closure Tray Model 7554 Recalled for Non-Sterility
FDA (Devices) · 2026-04-29
Similar recalls
- CriticalPharmacy Creations Recalls Ascorbic Acid Injection Vials Due to Mold Contamination
FDA (Drugs) · 2014-08-27
- SeverePharmacy Creations Recalls EDTA Disodium Injection Due to Sterility Concerns
FDA (Drugs) · 2013-09-18
- SeverePharmacy Creations Recalls Lidocaine Injection Due to Sterility Concerns
FDA (Drugs) · 2013-09-18
- SevereAscorbic Acid Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2021-12-08
- SevereFDA Recalls Injectable Ascorbic Acid Vials Due to Sterility Concerns
FDA (Drugs) · 2014-11-12
- SevereAscorbic Acid Injectable Vials Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23